Last update 20 Mar 2025

TXN-10128

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
N-[3-fluoro-4-(5-methoxy-1H-benzo[d][1,2,3]triazol-1-yl)phenyl) methylsulfamide
Target
ENPP1
Action
inhibitors
Mechanism
ENPP1 inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Locally Advanced Malignant Solid NeoplasmPancreatic Cancer
Inactive Indication-
Originator Organization
Txinno Bioscience Co., Ltd.Txinno Bioscience Co., Ltd.Startup
Active Organization
Txinno Bioscience Co., Ltd.Txinno Bioscience Co., Ltd.Startup
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Related

1
Clinical Trials associated with TXN-10128
NCT05978492
/ RecruitingPhase 1
A Multicenter, Open-label, Phase 1 Dose Escalation and Expansion Study of TXN10128, an Inhibitor of ENPP1 in Subjects With Locally Advanced (Unresectable) or Metastatic Solid Tumors
100 Clinical Results associated with TXN-10128
Login to view more data
100 Translational Medicine associated with TXN-10128
Login to view more data
100 Patents (Medical) associated with TXN-10128
Login to view more data
100 Deals associated with TXN-10128
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Locally Advanced Malignant Solid NeoplasmPhase 1
South Korea
Txinno Bioscience Co., Ltd.Txinno Bioscience Co., Ltd.Startup
27 Jul 2023
Pancreatic CancerPreclinical
United States
Txinno Bioscience Co., Ltd.Txinno Bioscience Co., Ltd.Startup
15 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free